Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Raise more money to buy back stock and still vote on a reverse split. Certainly, an interesting approach when you already have $50+M cash on hand. The only signal that sends is a big FU to investors.
The stock market is rigged for the rich...
period.
At these prices and with $54M cash on hand PULM should buy back half the float.
The Huge Diluting Pos Scam crashed to $0.6 today! Sell ASAP before it is too late...
Why PULM crashed from the most recent high $1.05 to such low price levels without any bad news? Did I miss any negative bad news?
How could my buying order at $0.6201 was not filled any yesterday but the price dropped to much below it?
I had buying orders at 0.6201 all the way till 0.5 yesterday! Why no any fill at all?
Anyway the Real Bottom is $0.6201 as I can tell!
Thanks for sharing your opinion. I humbly disagree.
$PULM
LOL, the Huge Diluting Pos Scam (PULM) crashed to $0.7667 again in the after-hour session of last Friday! So the New low $0.67 will be tested again in the coming days...
I bet $0.5xxx will be the New Bottom before any decent bounce!
Why? I dont see a catalist for this..,
I like the way you think.
lol barking up the wrong tree here .
$PULM Hard to believe that the future is not bright here.
This company has a $43M market cap (risk has been taken out), $40M
+ cash on hand with multi-year runway, no debt, granted IP approvals, FDA & MHRA approvals, distinguished scientific advisors, distinguished founders, great royalty deal on a coming new form of airway hygiene, a pipeline which assuming can be commercialized is worth billions, in-roads with some of the largest pharma companies in the world -- and a repeatable delivery platform which just needs that one breakthrough example to prove to the market.
Advice is being given to management by people who have been in this industry for a long time. Ted is not a science guy he is a business guy. Management and employee compensation package are tied to prices $1.30++. Warrant holders are tied to $2.00+ prices.
$2.00 is only a $100M market cap (lol!). The risk/reward ratio here is extremely favorable at this point in time.
In my opinion, obviously.
I like our odds. Breakthrough news coming... (?)
CIPLA? Hello, anyone home? PUR1900 LPAD?
FEND? Hello, new product launch?
J&J? Hello, are you interested in PUR1800 for Lung Cancer with chronic dosing showing improved safety profile?
Nocion? Hello, iSPERSE is there once your API clears
$PULM
Oh, you're fun.
Or maybe a bounce from here.
One could hope anyway.
$PULM
Why iSPERSE; 2012 Article; Still True Today
Will we see iSPERSE be live up to it's long-promised benefits?
https://drug-dev.com/a-next-generation-inhaled-dry-powder-delivery-platform/
PUR1900 Study Status Update as of 8/25/21 as well? Coinciding?
https://clinicaltrials.gov/ct2/history/NCT03960606?V_8=View#ROutcomeMeasures
$PULM
Cipla Positive PUR1900 Comment in Annual Report (8/25/21)
The six months animal toxicitystudy for Pulmazole concluded successfully. We are now moving to a global Phase 2b study and a possible India Phase 2b/3 study for antifungal inhaled Itraconazole
$PULM
Page 44
https://www.cipla.com/sites/default/files/CIPLA-AR-2020-21-Single-Page.pdf
$PULM $0.82 -- let it rip. Global Ubiquity coming for FEND & iSPERSE.
....! Let's see the push now.
$PULM
$PULM , just added some more...
R/S not a thought here. Cash on hand $55M, Market Cap $47M. Value of iSPERSE + FEND royalties implied at negative. That's funny.
Momentum is turning. News is coming.
$PULM
Yes, can't remember when exactly, but 1/100 I think.
$PULM
Has PULM done an RS in the past? I've only been in this position for about 12 months.
Hopefully organically, real news, real pumping, not another RS. My RearSection is sore enough already.
$PULM
There we go. News we were all waiting for, failure to meet the minimum listing price of $1.00. 6 months to regain compliance I expect we'll see a wave of communication from an otherwise dead PR department. I'm doubling down.
Time to Buy $PULM - $0.77
THEY need to get this back over $1. I've already been f'd, but I don't want anyone else to be. Hopefully they get correct soon.
$PULM
FEND effective Vs Delta Variant? Listen to David Himself from the 6/28 Public Discourse.
"But what happened is we were doing a study in Covid-19 patients in Banglore, and when the delta variant began to spread as rapidly as it did, the decision was made was to treat incoming patients, so randomized control study, with a nasal saline control -- was started in the February (2021) timeframe -- and we are just now submitting for publication the research.
Very high level, remarkably, treating 3-times a day of FEND, has a significant impact on lowering symptoms and also raising oxygen pressure in the blood which is a measure of your lung's ability to bring oxygen into your blood and also reduces IV/Steroid/Antibiotic use relative to the control -- so we are very hopeful that this really simple intervention could be very impact -- particularly in locations like an India today which may not have immediate access to vaccines."
Starting at 10:37-12:20
PUR1800 Tox Results in Q3 2021;
JnJ seems likely to re-enter for Lung Cancer Indication upon chronic dosage showing safety levels.
$PULM
Robert Langer joined the Next Breath Board
https://nextbreath.global/about-us
$PULM
July 5th -- Next Breath Launching a FEND Initiative, per the Next Breath Website.
https://nextbreath.global/what-is-next-breath
$PULM
Third time's a charm
Yeah… again… for the third time… time is here…
The time is here
$PULM
*Pulmatrix Files For Mixed Shelf Of Up To $100M
Benzinga May 26, 2021
5:10 pm ET
About to wake up from long slumber.
$PULM
63 million cash and equivalents on hand....they can fund their trials by themselves for quite a while
$$$$$$$$$$$$$$$$$$$$$ PULMATRIX $$$$$$$$$$$$$$$$$$$$....gla
Followers
|
72
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
3552
|
Created
|
10/21/15
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |